Ohio Public Employees Retirement System (OPERS)’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$101K Sell
13,312
-8,514
-39% -$64.4K ﹤0.01% 1772
2025
Q1
$120K Buy
21,826
+6,100
+39% +$33.7K ﹤0.01% 1739
2024
Q4
$90.4K Buy
15,726
+8,501
+118% +$48.9K ﹤0.01% 1790
2024
Q3
$74.9K Hold
7,225
﹤0.01% 1683
2024
Q2
$93.7K Sell
7,225
-437
-6% -$5.67K ﹤0.01% 1438
2024
Q1
$134K Sell
7,662
-24,735
-76% -$432K ﹤0.01% 1395
2023
Q4
$305K Buy
32,397
+6,533
+25% +$61.5K ﹤0.01% 1330
2023
Q3
$289K Hold
25,864
﹤0.01% 1313
2023
Q2
$553K Hold
25,864
﹤0.01% 1264
2023
Q1
$1.05M Hold
25,864
﹤0.01% 1151
2022
Q4
$1.2M Sell
25,864
-5,871
-19% -$273K 0.01% 1121
2022
Q3
$1.65M Buy
31,735
+25,237
+388% +$1.31M 0.01% 1097
2022
Q2
$307K Sell
6,498
-8,507
-57% -$402K ﹤0.01% 1414
2022
Q1
$1.07M Buy
15,005
+4,060
+37% +$289K ﹤0.01% 1223
2021
Q4
$818K Buy
10,945
+6,625
+153% +$495K ﹤0.01% 1281
2021
Q3
$245K Hold
4,320
﹤0.01% 1459
2021
Q2
$190K Hold
4,320
﹤0.01% 1529
2021
Q1
$213K Hold
4,320
﹤0.01% 1470
2020
Q4
$182K Hold
4,320
﹤0.01% 1442
2020
Q3
$198K Hold
4,320
﹤0.01% 1349
2020
Q2
$217K Buy
+4,320
New +$217K ﹤0.01% 1365
2019
Q4
Sell
-13,586
Closed -$816K 1893
2019
Q3
$816K Hold
13,586
﹤0.01% 1231
2019
Q2
$1.15M Sell
13,586
-4,015
-23% -$339K 0.01% 1160
2019
Q1
$1.68M Hold
17,601
0.01% 1045
2018
Q4
$1.25M Buy
17,601
+244
+1% +$17.3K 0.01% 1062
2018
Q3
$1.48M Sell
17,357
-2,218
-11% -$190K 0.01% 1118
2018
Q2
$2.27M Buy
19,575
+5,989
+44% +$694K 0.01% 984
2018
Q1
$1.1M Sell
13,586
-5,027
-27% -$407K 0.01% 1229
2017
Q4
$1.09M Sell
18,613
-2,031
-10% -$119K 0.01% 1239
2017
Q3
$966K Hold
20,644
0.01% 1255
2017
Q2
$743K Sell
20,644
-5,336
-21% -$192K ﹤0.01% 1277
2017
Q1
$800K Buy
25,980
+3,625
+16% +$112K ﹤0.01% 1211
2016
Q4
$630K Buy
22,355
+3,146
+16% +$88.7K ﹤0.01% 1260
2016
Q3
$511K Hold
19,209
﹤0.01% 1293
2016
Q2
$424K Buy
19,209
+747
+4% +$16.5K ﹤0.01% 1274
2016
Q1
$542K Buy
18,462
+6,335
+52% +$186K ﹤0.01% 1221
2015
Q4
$400K Buy
12,127
+7,571
+166% +$250K ﹤0.01% 1292
2015
Q3
$165K Buy
+4,556
New +$165K ﹤0.01% 1483